IDEXX Laboratories, Inc.IDXXNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +6.56% | +5.84% | +3.56% | +10.55% | +13.29% |
| Gross Profit Growth | +8.77% | +8.46% | +5.11% | +11.89% | +14.65% |
| EBITDA Growth | +11.83% | +7.14% | +5.16% | +36.15% | +14.64% |
| Operating Income Growth | +10.39% | +6.68% | +5.88% | +41.41% | +16.77% |
| Net Income Growth | +9.71% | +11.12% | +3.01% | +44.61% | +17.94% |
| EPS Growth | +10.98% | +12.39% | +4.93% | +48.78% | +21.20% |
| EPS Diluted Growth | +10.67% | +12.93% | +5.34% | +48.77% | +21.43% |
| Weighted Average Shares Growth | -0.95% | -1.49% | -2.14% | -2.68% | -2.68% |
| Weighted Average Shares Diluted Growth | -1.12% | -1.66% | -2.42% | -2.88% | -2.87% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -19.22% | +4.87% | +19.83% | -25.20% | +82.82% |
| Free Cash Flow Growth | -19.45% | +2.52% | +23.54% | -29.47% | +93.36% |
| Receivables Growth | +12.49% | +6.00% | +4.48% | +9.07% | +21.79% |
| Inventory Growth | -1.06% | +0.42% | +1.38% | +3.32% | +0.45% |
| Asset Growth | +8.57% | +1.03% | -4.17% | -2.46% | +1.07% |
| Book Value per Share Growth | +25.92% | +9.09% | -5.69% | -5.14% | -0.85% |
| Debt Growth | -12.44% | -7.53% | -0.90% | +15.86% | +11.49% |
| R&D Expense Growth | +12.53% | +11.42% | +12.21% | +11.63% | +17.48% |
| SG&A Expenses Growth | +5.98% | +9.69% | +2.61% | -13.38% | +11.31% |